http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014018558-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ad879d58f607b11e89adc360e589b37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-09
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-03
filingDate 2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c9fe4197b68a61c63b3a28a47aed916
publicationDate 2014-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014018558-A1
titleOfInvention Docosahexaenoic acid (dha) as polyunsaturated free fatty acid in its directly compressible powder form and method of isolation thereof
abstract The present invention provides Docosahexaenoic acid (DHA) in its free fatty acid form and a process of isolation thereof from oils and fats of natural origin having Docosahexaenoic acid (DHA) attached to triglycerides. The DHA isolated using the process of the present invention is in free flowing powder form which is directly compressible. Further, the DHA in powder form is free from triglycerides. The DHA powder of the present invention has purity more than 90%. The DHA in its free fatty acid powder form offers excellent bioavailability and stability at room temperature.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021023849-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019034698-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019008101-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021023857-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016381663-A1
priorityDate 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007059340-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403419
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID30960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445580
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID27697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228136554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127831433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18521
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID30960
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID27697
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127794012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19087499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452039323
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID224708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175542
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1907177
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1907177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127973885
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID224708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10883

Total number of triples: 43.